Sandra and Edward Meyer Cancer Center

You are here

News

Loredana Puca, Ph.D.
2017 Jan 12

Exploring epigenetic therapy for aggressive prostate cancer

With the help of a 2016 Lori Milken–PCF Young Investigator Award from the Prostate Cancer Foundation, Loredana Puca, Ph.D., is studying the genomic characteristics of neuroendocrine prostate cancer and whether it might be possible to develop an epigenetic therapy to treat it. Read more
cervical cancer, endometrial cancer, ovarian cancer, uterine cancer, vaginal, vulvar, carcinosarcoma, leiomyosarcoma, mullerian tumors
2017 Jan 11

Weill/NYP support updated HPV vaccine recommendations

NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation’s top healthcare institutions in supporting revised vaccination guidelines from the Centers for Disease Control and Prevention (CDC) for the human papillomavirus (HPV). Read more
Ari Melnick, M.D.
2017 Jan 05

Tailored organoid may help unravel immune response mystery

An Ithaca-NYC team has developed a modular immune organoid that can replicate the anatomical structures found within lymph nodes to mimic the early stages of a germinal center, where B cell differentiation and initiation of immunological responses take place during infection. Read more
Photo of Dr. Shahin Rafii
2016 Dec 15

Corrupted tumor blood vessels spawn cancer stem cells

The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy, according to a new study by a team of researchers led by Shahin Rafii. Read more

Newsletters

April 2015 

May 2015

June 2015

December 2015

February 2016

April 2016

July 2016

October 2016

Cancer prevention at Weill Cornell Medicine, NewYork-Presbyterian Hospital in NY

Cancer Prevention Newsletter

Meyer Cancer Center is a partner with OncLive, the official Website for the Oncology Specialty Group.

Twitter Feed